Enanta Pharmaceuticals, Inc.
Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
Last updated:
Abstract:
The present invention provides compounds of Formula (I) or Formula (II): ##STR00001## pharmaceutical compositions comprising these compounds and methods of using these compounds to treat or prevent a disease or disorder mediated by FXR and/or TGR5.
Status:
Grant
Type:
Utility
Filling date:
22 Feb 2017
Issue date:
30 Jul 2019